Please Wait.....
Report
Consumer Health in France
Market Direction I 2024-09-17 I 128 Pages I Euromonitor
At first glance, consumer health in France appears to exhibit robust current value growth in 2024, similar to the performance observed in 2023. However, industry players express considerable disappointment regarding volume progression. In light of a challenging economic environment, French households are increasingly favouring prescribed OTC products in order to benefit from reimbursement. This shift positively impacts pure OTC products but does not translate into sufficient volume growth. Value...
Euromonitor International's Consumer Health in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Consumer Health in France
Euromonitor International
September 2024
List Of Contents And Tables
CONSUMER HEALTH IN FRANCE
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Analgesics beset by challenges in 2024
Despite the popularity of acetaminophen, ibuprofen's woes erode overall category potential
Doliprane's popularity consolidates Sanofi's leadership position, while consumers fret over dearth of medical professionals
PROSPECTS AND OPPORTUNITIES
Self-medication on the rise, but uncertainty around pseudoephedrine dampens expectations for overall category
Retailers and manufacturers look to avoid shortages
Sanofi to divest itself of consumer health arm
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
2024 sees modest sales performance
Combination products witness another year of double-digit decline amid pseudoephedrine controversy
Ricola benefits from French consumers' sweet tooth
PROSPECTS AND OPPORTUNITIES
As flu seasons settle down the impact will be offset by rising demand for antihistamines/allergy remedies
More innovation necessary amid intensifying competition, while ageing population will help to sustain sales
Growing preference among local consumers for natural remedies
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
DIGESTIVE REMEDIES IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Robust growth results from consumer stress and sharp price hikes
Tourism boost helps motion sickness remedies, while Johnson & Johnson leads by a slight margin
Focus on gut health and demand for probiotics present challenge to growth
PROSPECTS AND OPPORTUNITIES
Stress and ageing to maintain future category growth
PPIs faces concerns over possible product misuse
Natural alternatives pose threat to OTC remedies
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2019-2024
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
DERMATOLOGICALS IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Dermatologicals deemed less important than other OTC offerings during times of financial uncertainty
Growth driven by return to pre-pandemic patterns
Stress and anxiety boost performance of hair loss treatments
PROSPECTS AND OPPORTUNITIES
Demographic and climate issues set to impact forecast performance
Continuous challenge from unclear positioning for dermatologicals
Under-exploited potential for vaginal antifungals, while medicated shampoos will maintain stable sales
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2019-2024
Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
NRT SMOKING CESSATION AIDS IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Reimbursement remains key for category, limiting OTC penetration
Oral formats dominate, while players focus on mobile apps
Leading players take divergent approaches to boosting sales
PROSPECTS AND OPPORTUNITIES
Category will struggle over the forecast period
E-vapour products remain a serious competitive threat
Natural products unlikely to make any headway in NRT smoking cessation aids
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2019-2024
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
SLEEP AIDS IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Sleep aids continues to reap benefits from consumer stress and anxiety
Gummies gain rapid ground
Sanofi's Novanuit remains overall leader
PROSPECTS AND OPPORTUNITIES
Demand set to continue throughout forecast period, despite challenges ahead
Possible new competition from other consumer health options
Potential for expansion in sea magnesium, melatonin and CBD
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2019-2024
Table 45 Sales of Sleep Aids: % Value Growth 2019-2024
Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024
Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024
Table 48 Forecast Sales of Sleep Aids: Value 2024-2029
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
EYE CARE IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Increase in pollen and airborne allergens boost category performance
Modern lifestyles also aid performance
Competitive landscape remains stable
PROSPECTS AND OPPORTUNITIES
Rising prevalence of myopia in France
Demand for eye care to forge ahead over the forecast period
OTC eye care evolves amid ophthalmologist shortages
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2019-2024
Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024
Table 52 NBO Company Shares of Eye Care: % Value 2020-2024
Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024
Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029
WOUND CARE IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Poor performance for wound care in 2024
URGO maintains leadership of overall wound care
Ongoing threat to pharmacies from grocery retail
PROSPECTS AND OPPORTUNITIES
Maturity contributes to forecast disappointing performance
Pure online and private label players hold further growth potential
Limited room for growth in products with value-added features
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2019-2024
Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
VITAMINS IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Return to pre-pandemic trends for vitamins in France
Multivitamins too expensive for many, as vitamin D recovers from previous year's dip
Bayer rises in 2024
PROSPECTS AND OPPORTUNITIES
Growth set to continue during forecast period, benefitting from dietary trends
Multivitamin growth to stay stable
Vitamin D recommendation expected to accelerate growth
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2019-2024
Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024
Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024
Table 65 NBO Company Shares of Vitamins: % Value 2020-2024
Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024
Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
DIETARY SUPPLEMENTS IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Another strong year of growth as consumers continue to opt for natural fixes
Category-wide dynamism is thanks to the promise of functional ingredients
Dermapharm leads while BMS enters the category with innovative offering
PROSPECTS AND OPPORTUNITIES
Favourable outlook thanks to increased focus on more natural products
Social media activity expected to drive growth
Pharmacies likely to reinforce leadership, as players focus more on benefits of eye health products
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2019-2024
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024
Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
WEIGHT MANAGEMENT AND WELLBEING IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Weight management and wellbeing continues to suffer in 2024
Evolving demand undermines interest in traditional category products
Detox, drainage and gummies
PROSPECTS AND OPPORTUNITIES
Category faces difficult road ahead
Customised coaching and new approaches
Ongoing development for supplement nutrition and slimming teas
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
SPORTS NUTRITION IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Growth driven rising numbers of athletes interested in endurance sports and fitness
Explosion of gyms versus running and home-based training
Mainstream players face a new generation of competitors
PROSPECTS AND OPPORTUNITIES
Plenty of room for growth in a still-evolving market
Players to focus on finding new target audiences
Anticipated influx of new products and formats
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2019-2024
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
HERBAL/TRADITIONAL PRODUCTS IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
French consumers continue to shift towards herbal/traditional products
Sleep issues and stress support sales, as natural trends gain traction
Dermapharm as leading GBO through acquisition of Laboratoires Arkopharma, and demand for CBD-based variants rises rapidly
PROSPECTS AND OPPORTUNITIES
Ongoing favourable outlook for herbal/traditional products
NRT smoking cessation aids unlikely to be impacted by herbal and natural trends
Rising digestive complaints will support further category growth
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029
PAEDIATRIC CONSUMER HEALTH IN FRANCE
KEY DATA FINDINGS
2024 DEVELOPMENTS
Ambivalent performance from paediatric consumer health in 2024
Non-chemical lice treatments gain momentum
Naturalness trend spreads throughout overall category
PROSPECTS AND OPPORTUNITIES
Changing demographics present challenges to growth
Rising demand for paediatric vitamins and dietary supplements with natural positioning
Paediatric consumer health to be further affected by shortages
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security